Jamie Clark
Stock Analyst at Rothschild & Co
(2.40)
# 2,520
Out of 5,241 analysts
9
Total ratings
71.43%
Success rate
8.14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $302.89 | +2.68% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $415.27 | +14.14% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $116.38 | +102.78% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $150.85 | +20.65% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $250.40 | +10.22% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $186.61 | +4.50% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $169.12 | +63.20% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $302.89
Upside: +2.68%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $415.27
Upside: +14.14%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $116.38
Upside: +102.78%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $150.85
Upside: +20.65%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $250.40
Upside: +10.22%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $186.61
Upside: +4.50%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $169.12
Upside: +63.20%